137 related articles for article (PubMed ID: 32089222)
1. Secondary Acute Myeloid Leukemia: A Primary Challenge of Diagnosis and Treatment.
Winer ES
Hematol Oncol Clin North Am; 2020 Apr; 34(2):449-463. PubMed ID: 32089222
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.
Auerbach S; Puka B; Golla U; Chachoua I
Life (Basel); 2024 Feb; 14(3):. PubMed ID: 38541635
[TBL] [Abstract][Full Text] [Related]
3. Opportunities for immunotherapy in childhood acute myeloid leukemia.
Lamble AJ; Tasian SK
Blood Adv; 2019 Nov; 3(22):3750-3758. PubMed ID: 31770440
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia: Current understanding and management.
Becker M; Farina KA; Mascarenhas J
JAAPA; 2024 Jan; 37(1):34-39. PubMed ID: 38128137
[TBL] [Abstract][Full Text] [Related]
5. WHO, what, when, where, and why: New classification systems for acute myeloid leukemia and their impact on clinical practice.
Appelbaum FR
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101518. PubMed ID: 38092471
[TBL] [Abstract][Full Text] [Related]
6. Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects.
Eckardt JN; Bornhäuser M; Wendt K; Middeke JM
Blood Adv; 2020 Dec; 4(23):6077-6085. PubMed ID: 33290546
[TBL] [Abstract][Full Text] [Related]
7. JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
Maeda Y
Int J Hematol; 2024 Apr; 119(4):347-373. PubMed ID: 38483689
[No Abstract] [Full Text] [Related]
8. Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Hochman MJ; Othus M; Hasserjian RP; Ambinder A; Brunner A; Percival MM; Hourigan CS; Swords R; DeZern AE; Estey EH; Karp JE
Leukemia; 2023 Sep; 37(9):1915-1918. PubMed ID: 37524919
[TBL] [Abstract][Full Text] [Related]
9. Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions.
Meillon-Garcia LA; Demichelis-Gómez R
Curr Oncol Rep; 2020 Oct; 22(12):125. PubMed ID: 33025161
[TBL] [Abstract][Full Text] [Related]
10. How I treat acute myeloid leukemia presenting with preexisting comorbidities.
Ofran Y; Tallman MS; Rowe JM
Blood; 2016 Jul; 128(4):488-96. PubMed ID: 27235136
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Heuser M; Ofran Y; Boissel N; Brunet Mauri S; Craddock C; Janssen J; Wierzbowska A; Buske C;
Ann Oncol; 2020 Jun; 31(6):697-712. PubMed ID: 32171751
[No Abstract] [Full Text] [Related]
12. Management Principles and Advances in Therapies of Pediatric Acute Leukemia: A Comprehensive Snapshot.
Ganguly S; Ravindranath Y; Bakhshi S
Indian J Pediatr; 2024 Jan; 91(1):35-36. PubMed ID: 37945980
[No Abstract] [Full Text] [Related]
13. [The guidelines for diagnosis and treatment of relapse /refractory acute myelogenous leukemia in China (2023)].
Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):713-716. PubMed ID: 38049313
[No Abstract] [Full Text] [Related]
14. Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.
Termini CM; Moseley A; Othus M; Appelbaum FR; Chauncey TR; Erba HP; Fang M; Lee SC; Naru J; Pogosova-Agadjanyan EL; Radich JP; Willman CL; Wu F; Meshinchi S; Stirewalt DL
Haematologica; 2023 Nov; 108(11):3148-3151. PubMed ID: 37021537
[No Abstract] [Full Text] [Related]
15. Understanding the barriers to AML care in India.
Senapati J; Panda T; Rajendra A; Aggarwal M
Lancet Haematol; 2023 Sep; 10(9):e710-e711. PubMed ID: 37652600
[No Abstract] [Full Text] [Related]
16. Making AML fly too close to the sun.
Bullinger L; Krönke J
Blood; 2024 Apr; 143(15):1438-1439. PubMed ID: 38602697
[No Abstract] [Full Text] [Related]
17. Changing the paradigm of AML care in India.
Singh A; Jain A; Tabbassum H; Siraj F; Rishi B; Misra A
Lancet Haematol; 2024 Jan; 11(1):e9. PubMed ID: 38135376
[No Abstract] [Full Text] [Related]
18. AML gets upSET when its dietary needs are unMet.
Gallipoli P
Blood; 2022 Nov; 140(19):2003-2004. PubMed ID: 36355468
[No Abstract] [Full Text] [Related]
19. Risk factors for survival in patients with acute myeloid leukemia.
Kawada T
J Formos Med Assoc; 2024 Jan; 123(1):136. PubMed ID: 37385934
[No Abstract] [Full Text] [Related]
20. Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people.
Juliusson G; Höglund M; Lehmann S
Haematologica; 2020; 105(2):249-251. PubMed ID: 32005651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
